L
LTCure develops and commercializes novel small molecule therapeutics targeting the underlying mechanisms of neurodegenerative diseases. The company focuses on developing disease-modifying treatments for conditions like Alzheimer's and Parkinson's disease. Their pipeline utilizes proprietary chemistry to create orally bioavailable compounds with high specificity for therapeutic targets.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- LTCure develops and commercializes novel small molecule therapeutics targeting the underlying mechanisms of neurodegenerative diseases. The company focuses on developing disease-modifying treatments for conditions like Alzheimer's and Parkinson's disease. Their pipeline utilizes proprietary chemistry to create orally bioavailable compounds with high specificity for therapeutic targets.